The company's leading product, GLURENORM, is a non-insulin-dependent hypoglycemic drug. Tang Shiping was first introduced to China by the Ministry of Health. On February 26th, 199 165438+ approved the trial production, and on March 3rd, 1994 officially put into production. This product has little toxic and side effects, and it is the only hypoglycemic agent that can be selected for diabetic nephropathy. At the same time, the dosage can be adjusted according to the patient's condition, and it can be combined with a variety of hypoglycemic drugs. It is stable and mild, suitable for long-term use, and is well received by the majority of diabetic patients. Since the listing of Tang Shiping, it has won many honors, and 1992 won the excellent new product of Beijing municipal level. In 2000, 2002 and 2004, it was rated as a famous brand product in Beijing. Tang Shiping has been listed for more than ten years, and the sales of its products have maintained a high-speed growth trend. Since 2000, the sales of single varieties in Tang Shiping have exceeded 100 million yuan for five consecutive years. The sales of this product account for 20% of the similar drug market, and it has formed a large scale as a single product.
Beijing Wan Hui Shuanghe Pharmaceutical Co., Ltd. adheres to the enterprise tenet of "caring for the public, healthy people's livelihood" and the quality concept of "high technology, high standard and zero defect", and strives to build the first brand of hypoglycemic in China and serve customers at home and abroad wholeheartedly with high-quality products.